what happens when you stop taking glp-1 drugs New research is a closer look at can happen a year or more after people taking medications The GLP-1 Agonists and Obesity:

PMID: 33144906

Consistent with this, we demonstrate that treatment with MK-801, even at doses that do not evoke weight loss, elicits pronounced hyperthermia in DIO mice (Extended Data Fig

Your muscles become better at taking in and using glucose for energy

TOLERABILITY AND ADVERSE EVENTS The most common adverse events associated with GLP-1 receptor agonist use in general are gastrointestinal in nature, with mild-to-moderate diarrhea, nausea, and vomiting being the most commonly reported events

Targeting Glucose-Dependent Insulinotropic Polypeptide Receptor for Neurodegenerative Disorders

Dhillon, S., & Semaglutide (2018)